MET

Over the past six months (approximately April to October 2026), MetLife's stock price increased by 18.27% over the last 12 months and 1.63% in the past month, reaching $94.16 as of September 30, 2026, a 14.93% increase from October 1, 2025. Key influencing factors include positive analyst sentiment with reiterated 'Buy' ratings and raised price targets, a new $3 billion share buyback authorization, a declared quarterly common stock dividend of $0.5925, higher long-term Treasury yields acting as a tailwind for investment income, strong demand for pension risk transfer, and upcoming third-quarter results (due November 4, 2026) with an expected pre-tax variable investment income of at least $600 million. The stock has also been influenced by broader market trends, bond sell-offs, and the financial sector's performance.